l-glutamine and l-glutathione Basis for the use of to treat sickle cell disease. Intense 350-004 CL - RPMI 1640

Gao et al., 2023

In yet another aspect, there is provided a method of sensitizing cancer cells in a subject to cytotoxic CD8+ T cell-mediated killing and/or immune checkpoint therapy, the method comprising administering to the subject a therapeutically effective amount of a) at least one agent that down-regulates the copy number, amount, and/or activity of at least one target listed in table 1 in or on monocytes and/or macrophages

Progressive overload, gradually increasing weights or repetitions over time, maintains the adaptation signal even as body weight decreases

302 (1), H167H179

Ceruloplasmin metabolism and function